Lurie Children’s Division of Allergy and Immunology is at the cutting edge of food allergy clinical research. We offer our patients with food allergy the newest treatments as well as opportunities to be part of studies in hopes to discover more treatments and a cure.
We are currently recruiting patients in numerous food allergy studies. Learn more about our current trials:
POSEIDON: Peanut Oral Immunotherapy Study of Early Intervention for Desensitization This study looks at the long term safety of peanut desensitization using AR101 in children 1 to 3 years old. Click here for the full study information or call (312) 227-6474 for more information.
PARK - Preventing Asthma in High Risk Kids This study is trying to determine if giving a medicine called omalizumab to high risk children will decrease their chance of getting asthma or decrease the severity of their asthma. Click here for the full study information or call (312) 227-6474 for more information.
Infants with Moderate-Severe Eczema and/or Egg Allergy and Peanut Allergy: Discovering a Significant Genotype This study of children 4 - 11 months with moderate to severe eczema or egg allergy looks to find biomarkers to help tell us whether or not a child will develop a peanut allergy and how severe a peanut allergy might be. Click here for the full study information or call 312-227-5391 for more information.
For more information about our food allergy studies, please contact:
The Center for Food Allergy and Asthma Research (CFAAR), part of the Institute for Public Health and Medicine (IPHAM) at Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago, aims to find answers and shape policies surrounding food allergy, asthma and other allergic conditions.
Led by Ruchi Gupta, MD, MPH, CFAAR is comprised of three interdisciplinary and collaborative research cores: 1.) Public Health Data Repository Core, 2.) Clinical Research Core and 3.) Community/School Outreach Core. These cores are led by experts in the fields of epidemiology, health services research, health behavior, patient care, and advocacy seeking to make meaningful improvements in the health of children, adults, and families living with allergic disease.